These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 9500751)

  • 1. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. Salmeterol Quality of Life Study Group.
    Kemp JP; Cook DA; Incaudo GA; Corren J; Kalberg C; Emmett A; Cox FM; Rickard K
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):188-95. PubMed ID: 9500751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness.
    Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA
    Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of inhaled salmeterol and oral zafirlukast in patients with asthma.
    Busse W; Nelson H; Wolfe J; Kalberg C; Yancey SW; Rickard KA
    J Allergy Clin Immunol; 1999 Jun; 103(6):1075-80. PubMed ID: 10359889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A twelve-week comparison of salmeterol and salbutamol in the treatment of mild-to-moderate asthma: a Canadian multicenter study.
    Boulet LP; Laviolette M; Boucher S; Knight A; Hébert J; Chapman KR
    J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):13-21. PubMed ID: 9003206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy.
    Fish JE; Israel E; Murray JJ; Emmett A; Boone R; Yancey SW; Rickard KA
    Chest; 2001 Aug; 120(2):423-30. PubMed ID: 11502639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salmeterol xinafoate in children on high dose inhaled steroids.
    Russell G; Williams DA; Weller P; Price JF
    Ann Allergy Asthma Immunol; 1995 Nov; 75(5):423-8. PubMed ID: 7583864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.
    Boonsawat W; Goryachkina L; Jacques L; Frith L
    Clin Drug Investig; 2008; 28(2):101-11. PubMed ID: 18211118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma.
    Wenzel SE; Lumry W; Manning M; Kalberg C; Cox F; Emmett A; Rickard K
    Ann Allergy Asthma Immunol; 1998 Jun; 80(6):463-70. PubMed ID: 9647268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
    Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
    JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.
    Busse WW; Casale TB; Murray JJ; Petrocella V; Cox F; Rickard K
    Am J Manag Care; 1998 Nov; 4(11):1579-87. PubMed ID: 10338904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salmeterol reduces the need for inhaled corticosteroid in steroid-dependent asthmatics.
    Nielsen LP; Pedersen B; Faurschou P; Madsen F; Wilcke JT; Dahl R
    Respir Med; 1999 Dec; 93(12):863-8. PubMed ID: 10653047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids do not prevent the development of tolerance to the bronchoprotective effect of salmeterol.
    Kalra S; Swystun VA; Bhagat R; Cockcroft DW
    Chest; 1996 Apr; 109(4):953-6. PubMed ID: 8635376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmeterol and fluticasone propionate (50/250 microg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers.
    Chapman KR; Ringdal N; Backer V; Palmqvist M; Saarelainen S; Briggs M
    Can Respir J; 1999; 6(1):45-51. PubMed ID: 10202220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes.
    Lockey RF; DuBuske LM; Friedman B; Petrocella V; Cox F; Rickard K
    Chest; 1999 Mar; 115(3):666-73. PubMed ID: 10084473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma.
    Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA
    Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.